FindTrial
Sign In

The correlation between serum TET1 and outcome in patients with acute cerebral infarction

The correlation between serum TET1 and outcome in patients with acute cerebral infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019486
Enrollment
Unknown
Registered
2018-11-13
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute cerebral infarction

Interventions

Acute cerebral infarction group:none

Sponsors

Department of Neurology, Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Older than or equal to 18 years of age; 2. Newly diagnosed patients with acute cerebral infarctionconfirmed by computed tomography or magnetic resonance imaging of the brain; 3. within 72 hours of symptom onset.

Exclusion criteria

Exclusion criteria: 1. Cerebral hemorrhage, subarachnoid hemorrhage; Severe heart, liver and kidney diseases, malignant tumors, immune system diseases; Conscious disorders or epilepsy patients; 2. Complications include Wright syndrome, autism, schizophrenia and psychiatric disorders, Alzheimer's disease, Huntington's disease, fetal alcohol spectrum disorders, fragile X-related tremors and/or ataxia syndrome, and brain tumors; 3. The time from onset to treatment was more than 3 days.

Design outcomes

Primary

MeasureTime frame
TET1;score of NIHSS;—

Countries

China

Contacts

Public ContactYe Xinchun

Affiliated Hospital of Xuzhou Medical University

xinchunye@gmail.com+86 18052268829

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026